These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25511766)

  • 1. Editorial: prolonged remission from hepatic encephalopathy with rifaximin.
    Orr JG; Hudson M
    Aliment Pharmacol Ther; 2015 Jan; 41(2):228. PubMed ID: 25511766
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis.
    Bajaj JS; Barrett AC; Bortey E; Paterson C; Forbes WP
    Aliment Pharmacol Ther; 2015 Jan; 41(1):39-45. PubMed ID: 25339518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Durability of rifaximin response in hepatic encephalopathy.
    Neff GW; Jones M; Broda T; Jonas M; Ravi R; Novick D; Kaiser TE; Kemmer N
    J Clin Gastroenterol; 2012 Feb; 46(2):168-71. PubMed ID: 22011586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rifaximin in the treatment of hepatic encephalopathy].
    Lata J; Hůlek P; Fejfar T; Spicák J; Drastich P; Marecek Z; Brůha R; Husová L; Senkyrík M
    Vnitr Lek; 2002 Jun; 48(6):578-82. PubMed ID: 12132365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rifaximin for hepatic encephalopathy in children. Case report].
    Malla I; Torres Cerino V; Villa A; Cheang Y; Giacove G; Pedreira A; Silva M
    Arch Argent Pediatr; 2011 Dec; 109(6):e113-5. PubMed ID: 22231877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifaximin therapy in minimal hepatic encephalopathy cirrhotics.
    Zullo A; Hassan C; Lorenzetti R
    Am J Gastroenterol; 2011 Nov; 106(11):2041; author reply 2041-2. PubMed ID: 22056578
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifaximin treatment in hepatic encephalopathy.
    Bass NM; Mullen KD; Sanyal A; Poordad F; Neff G; Leevy CB; Sigal S; Sheikh MY; Beavers K; Frederick T; Teperman L; Hillebrand D; Huang S; Merchant K; Shaw A; Bortey E; Forbes WP
    N Engl J Med; 2010 Mar; 362(12):1071-81. PubMed ID: 20335583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifaximin: an alternative for the treatment of hepatic encephalopathy.
    Rigali VT
    Conn Med; 2006 Sep; 70(8):499-501. PubMed ID: 17089807
    [No Abstract]   [Full Text] [Related]  

  • 9. Rifaximin treatment in hepatic encephalopathy.
    Wang CC; Kao JH
    N Engl J Med; 2010 Jun; 362(25):2423; author reply 2424-5. PubMed ID: 20573932
    [No Abstract]   [Full Text] [Related]  

  • 10. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
    Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
    Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifaximin treatment in hepatic encephalopathy.
    Xue T; Qiu JH; Qiao L
    N Engl J Med; 2010 Jun; 362(25):2424; author reply 2424-5. PubMed ID: 20578275
    [No Abstract]   [Full Text] [Related]  

  • 12. Rifaximin treatment in hepatic encephalopathy.
    Sharma P; Sharma BC
    N Engl J Med; 2010 Jun; 362(25):2423-4; author reply 2424-5. PubMed ID: 20578274
    [No Abstract]   [Full Text] [Related]  

  • 13. Gut flora and hepatic encephalopathy in patients with cirrhosis.
    Riordan SM; Williams R
    N Engl J Med; 2010 Mar; 362(12):1140-2. PubMed ID: 20335591
    [No Abstract]   [Full Text] [Related]  

  • 14. Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy.
    Kang SH; Lee YB; Lee JH; Nam JY; Chang Y; Cho H; Yoo JJ; Cho YY; Cho EJ; Yu SJ; Kim MY; Kim YJ; Baik SK; Yoon JH
    Aliment Pharmacol Ther; 2017 Nov; 46(9):845-855. PubMed ID: 28836723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifaximin is an efficacious treatment for the Parkinsonian phenotype of hepatic encephalopathy.
    Kok B; Foxton MR; Clough C; Shawcross DL
    Hepatology; 2013 Oct; 58(4):1516-7. PubMed ID: 23471844
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: rifaximin and minimal hepatic encephalopathy.
    Butterworth RF
    Am J Gastroenterol; 2011 Feb; 106(2):317-8. PubMed ID: 21301455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intestine specific broad spectrum antibiotic. Rifaximin: therapy option in hepatic encephalopathy].
    MMW Fortschr Med; 2014 Feb; 156(3):64-5. PubMed ID: 24938070
    [No Abstract]   [Full Text] [Related]  

  • 18. Rifaximin therapy and Clostridium difficile infection: a note of caution.
    Zullo A; Ridola L; Hassan C
    J Clin Gastroenterol; 2013 Sep; 47(8):737. PubMed ID: 23507769
    [No Abstract]   [Full Text] [Related]  

  • 19. Covert Hepatic Encephalopathy: Who Should Be Tested and Treated?
    Flamm SL
    Clin Liver Dis; 2015 Aug; 19(3):473-85. PubMed ID: 26195202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifaximin, a nonabsorbed oral antibiotic, in the treatment of hepatic encephalopathy: antimicrobial activity, efficacy, and safety.
    Williams R; Bass N
    Rev Gastroenterol Disord; 2005; 5 Suppl 1():S10-8. PubMed ID: 15976747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.